Anticonvulsant evaluation and mechanism of action of benzylamino enaminones

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 15, 2006, Pages 5266-5272

  Edafiogho, Ivan O ^a   Ananthalakshmi, Kethireddy V V ^a   Kombian, Samuel B ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Anticonvulsants; Enaminones; Mechanism; QSAR

Indexed keywords

3 BENZYLAMINOCYCLOHEX 2 EN 1 ONE; 4 BENZYLAMINO 6 METHYL 2 OXOCYCLOHEX 3 ENE (N BENZYL)CARBOXAMIDE; ANTICONVULSIVE AGENT; BENZYLAMINE DERIVATIVE; METHYL 4 BENZYLAMINO 6 METHYL 2 OXOCYCLOHEX 3 EN 1 OATE; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; IN VITRO STUDY; MOUSE; NONHUMAN; SEIZURE; SYNAPTIC TRANSMISSION;

ACTION POTENTIALS; ADMINISTRATION, ORAL; ANIMALS; ANTICONVULSANTS; BENZYLAMINES; CELLS, CULTURED; CYCLOHEXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIALS; MALE; MICE; MICE, INBRED STRAINS; MOLECULAR STRUCTURE; NEURONS; NUCLEUS ACCUMBENS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; STEREOISOMERISM;

EID: 33745177837     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.03.049     Document Type: Article

References (21)

1. Eddington N.D., Cox D.S., Roberts R.R., Stables J.P., Powell C.B., and Scott K.R. Curr. Med. Chem. 7 (2000) 417
2. Edafiogho I.O., Hinko C.N., Chang H., Moore J.A., Mulzac D., Nicholson J.M., and Scott K.R. J. Med. Chem. 35 (1992) 2798
3. Abou-Zeid, L.; Edafiogho, I. O. Health Sciences Poster Day 2002 and Ibn Sina Forum, Faculty of Medicine, Kuwait University, Kuwait, 2002, p. 178.
4. Dingledine R., McBain C.J., and McNamara J.O. Trends Pharmacol. Sci. 11 (1990) 334
5. McNamara J.O. Nature 399 (1999) A15
6. Edafiogho I.O., Denny B.J., Schwalbe C.H., and Lowe P.R. Med. Principles Practice 12 (2003) 237
7. Foster J.E., Nicholson J.M., Butcher R., Stables J.P., Edafiogho I.O., Goodwin A.M., Henson M.C., Smith C.A., and Scott K.R. Bioorg. Med. Chem. 7 (1999) 2415
8. Scott K.R., Edafiogho I.O., Richardson E.L., Farrar V.A., Moore J.A., Teitz E.I., Hinko C.N., Chang H., El-Assadi A., and Nicholson J.M. J. Med. Chem. 36 (1993) 1947
9. Edafiogho I.O., Moore J.A., Alexander M.S., and Scott K.R. J. Pharm. Sci. 83 (1994) 1155
10. CS ChemDraw Ultra version 6.01, C log P computer software by CambridgeSoft.Com.
11. Kombian S.B., Edafiogho I.O., and Ananthalakshmi K.V.V. Br. J. Pharmacol. 145 (2005) 945
12. Topliss J.G. J. Med. Chem. 15 (1972) 1006
13. Kubicki M., and Codding P.W. Acta Cryst. C 49 (1993) 2045
14. Armstrong N., and Gouaux E. Neuron 28 (2000) 165
15. Kotera K. Yakugaku Zasshi 80 (1960) 1275
16. Anticonvulsant Screening Project, Antiepileptic Drug Development program, National Institutes of Health, DHEW publ (NIH) (U.S.), 1978, NIH 78-1093.
17. Porter R.J., Cereghino J.J., Gladding G.D., Hessie B.J., Kupferberg H.J., Scoville B., and White B.G. Cleveland Clin. Q 51 (1984) 293
18. Krall R.L., Penry J.K., White B.G., Kupferberg H.J., and Swinyard E.A. Epilepsia 19 (1978) 400
19. Kombian S.B., Ananthalakshmi K.V.V., Parvathy S.S., and Matowe W.C. J. Neurophysiol 89 (2003) 728
20. Malawska B. Curr. Top. Med. Chem. 5 (2005) 69
21. Anderson A.J., Nicholson J.M., Bakare O., Butcher R.J., Wilson T.L., and Scott K.R. Bioorg. Med. Chem. 14 (2006) 997